Condition: Ankylosing Spondylitis · Sponsor: Shanghai Junshi Bioscience Co., Ltd.
This is a multicentre, randomized, double-blind, parallel, placebo-controlled Phase II clinical study of 261 adults with active ankylosing spondylitis to evaluate the efficacy and safety of JS005 in the treatment of active ankylosing spondylitis.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Beijing Chao-yang Hospital,Capital Medical University | Beijing, Beijing Municipality, China | — |
| Jilin Province People's Hospital | Jilin City, Changchun, China | — |
| Zhongshan Hospital Xiamen University | Xiamen, Fujian, China | — |
| The First Affiliated Hospital of Xiamen University | Xiamen, Fujian, China | — |
| Gansu Provincial Hospital | Lanzhou, Gansu, China | — |
| Dongguan People's Hospital | Dongguan, Guangdong, China | — |
| Sun Yat-sen Memorial Hospital | Guangzhou, Guangdong, China | — |
| Guangdong Provincial People's Hospital | Guangzhou, Guangdong, China | — |
| Zhujiang Hospital of Southren Medical University | Guangzhou, Guangdong, China | — |
| The Third Affiliated Hospital of Sun Yat-sen University | Guangzhou, Guangdong, China | — |
| Huizhou Central People's Hospital | Huizhou, Guangdong, China | — |
| Jieyang People's Hospital | Jieyang, Guangdong, China | — |
+ 26 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.